Michel Detheux, CEO of iTeos Therapeutics ($ITOS), sold shares on the open market 10 times over the past year, totaling $2.6 million. His most recent sale occurred on June 10, 2025. These $ITOS insider sales rank 2,941st among 11,678 individual insiders, below the average of $8.6 million per seller and 6.4 transactions. Detheux made no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 16, 2025 | Vor Biopharma Inc. | $VOR | Detheux Michel | Not found | A | Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 124,851,547 | 9999.99% | 0.05% |
| June 9, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | S | Common Stock | 8400 | $10.03 | 229,930.0000 | 38,194,341 | 3.52% | 0.02% |
| June 9, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | M | Common Stock | 43882 | $4.30 | 197,785.0000 | 38,194,341 | 28.51% | 0.11% |
| June 9, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | S | Common Stock | 43882 | $10.03 | 153,903.0000 | 38,194,341 | 22.19% | 0.11% |
| June 10, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | M | Common Stock | 8400 | $4.30 | 238,330.0000 | 38,194,341 | 3.65% | 0.02% |
| June 10, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | S | Common Stock | 8400 | $10.02 | 229,930.0000 | 38,194,341 | 3.52% | 0.02% |
| June 10, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | M | Common Stock | 43883 | $4.30 | 197,786.0000 | 38,194,341 | 28.51% | 0.11% |
| June 10, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | S | Common Stock | 43883 | $10.02 | 153,903.0000 | 38,194,341 | 22.19% | 0.11% |
| June 10, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | M | Common Stock | 18000 | $4.30 | 247,930.0000 | 38,194,341 | 7.83% | 0.05% |
| June 10, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | M | Common Stock | 94027 | $4.30 | 247,930.0000 | 38,194,341 | 61.09% | 0.25% |
| June 9, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | M | Stock Option (Right to Buy) | 8400 | $0.00 | 26,403.0000 | 38,194,341 | 24.14% | 0.02% |
| June 9, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | M | Stock Option (Right to Buy) | 43882 | $0.00 | 137,913.0000 | 38,194,341 | 24.14% | 0.11% |
| June 10, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | M | Stock Option (Right to Buy) | 8400 | $0.00 | 18,003.0000 | 38,194,341 | 31.81% | 0.02% |
| June 10, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | M | Stock Option (Right to Buy) | 43883 | $0.00 | 94,030.0000 | 38,194,341 | 31.82% | 0.11% |
| June 10, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | M | Stock Option (Right to Buy) | 18000 | $0.00 | 3.0000 | 38,194,341 | 99.98% | 0.05% |
| June 10, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | M | Stock Option (Right to Buy) | 94027 | $0.00 | 3.0000 | 38,194,341 | 100.00% | 0.25% |
| June 9, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | M | Common Stock | 8400 | $4.30 | 238,330.0000 | 38,194,341 | 3.65% | 0.02% |
| June 4, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | M | Common Stock | 8400 | $4.30 | 144,303.0000 | 38,194,341 | 6.18% | 0.02% |
| June 4, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | M | Common Stock | 43883 | $4.30 | 179,786.0000 | 38,194,341 | 32.29% | 0.11% |
| June 4, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | S | Common Stock | 43883 | $10.10 | 135,903.0000 | 38,194,341 | 24.41% | 0.11% |
| June 5, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | M | Common Stock | 8400 | $4.30 | 144,303.0000 | 38,194,341 | 6.18% | 0.02% |
| June 5, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | S | Common Stock | 8400 | $10.15 | 135,903.0000 | 38,194,341 | 5.82% | 0.02% |
| June 5, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | M | Common Stock | 43882 | $4.30 | 179,785.0000 | 38,194,341 | 32.29% | 0.11% |
| June 5, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | S | Common Stock | 43882 | $10.15 | 135,903.0000 | 38,194,341 | 24.41% | 0.11% |
| June 6, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | M | Common Stock | 8400 | $4.30 | 144,303.0000 | 38,194,341 | 6.18% | 0.02% |
| June 6, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | S | Common Stock | 8400 | $10.21 | 135,903.0000 | 38,194,341 | 5.82% | 0.02% |
| June 6, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | M | Common Stock | 43882 | $4.30 | 179,785.0000 | 38,194,341 | 32.29% | 0.11% |
| June 6, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | S | Common Stock | 43882 | $10.21 | 135,903.0000 | 38,194,341 | 24.41% | 0.11% |
| June 4, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | M | Stock Option (Right to Buy) | 8400 | $0.00 | 233,395.0000 | 38,194,341 | 3.47% | 0.02% |
| June 4, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | M | Stock Option (Right to Buy) | 43883 | $0.00 | 304,359.0000 | 38,194,341 | 12.60% | 0.11% |
| June 5, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | M | Stock Option (Right to Buy) | 8400 | $0.00 | 224,995.0000 | 38,194,341 | 3.60% | 0.02% |
| June 5, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | M | Stock Option (Right to Buy) | 43882 | $0.00 | 260,477.0000 | 38,194,341 | 14.42% | 0.11% |
| June 6, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | M | Stock Option (Right to Buy) | 8400 | $0.00 | 216,595.0000 | 38,194,341 | 3.73% | 0.02% |
| June 6, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | M | Stock Option (Right to Buy) | 43882 | $0.00 | 216,595.0000 | 38,194,341 | 16.85% | 0.11% |
| June 4, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | S | Common Stock | 8400 | $10.10 | 135,903.0000 | 38,194,341 | 5.82% | 0.02% |
| March 7, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | A | Stock Option (Right to Buy) | 459000 | $0.00 | 459,000.0000 | 38,194,341 | 9999.99% | 1.20% |
| March 7, 2025 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | A | Common Stock | 77000 | $0.00 | 135,903.0000 | 38,194,341 | 130.72% | 0.20% |
| Aug. 8, 2024 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | G | Stock Option (Right to Buy) | 442800 | $0.00 | 590,400.0000 | 0 | 42.86% | 0.00% |
| Aug. 8, 2024 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | G | Stock Option (Right to Buy) | 442800 | $0.00 | 590,400.0000 | 0 | 300.00% | 0.00% |
| March 7, 2024 | iTeos Therapeutics, Inc. | $ITOS | Detheux Michel | Chief Executive Officer | A | Stock Option (Right to Buy) | 590400 | $0.00 | 590,400.0000 | 0 | 9999.99% | 0.00% |